Literature DB >> 31073069

Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial.

Jin-Hua Liang1, Li Wang1, Hua-Yuan Zhu1, Jun Qian2, Hui Liao3, Jia-Zhu Wu1, Yi Xia1, Wei Wu1, Lei Cao1, Lei Fan1, Jian-Yong Li4, Wei Xu5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31073069      PMCID： PMC6939528          DOI： 10.3324/haematol.2019.220301

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society.

Authors:  J I Henter; M Aricò; R M Egeler; G Elinder; B E Favara; A H Filipovich; H Gadner; S Imashuku; G Janka-Schaub; D Komp; S Ladisch; D Webb
Journal:  Med Pediatr Oncol       Date:  1997-05

3.  Report on the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.

Authors:  Michel Meignan; Andrea Gallamini; Corinne Haioun; Sally Barrington; Emmanuel Itti; Stefano Luminari; Aaron Polliack
Journal:  Leuk Lymphoma       Date:  2015-05

Review 4.  Hemophagocytic lymphohistiocytosis in adults.

Authors:  Neel S Bhatt; Benjamin Oshrine; Julie An Talano
Journal:  Leuk Lymphoma       Date:  2018-07-03

5.  Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study.

Authors:  Hirozumi Sano; Ryoji Kobayashi; Junji Tanaka; Satoshi Hashino; Shuichi Ota; Yoshihiro Torimoto; Yasutaka Kakinoki; Satoshi Yamamoto; Mitsutoshi Kurosawa; Naoki Hatakeyama; Yoshihito Haseyama; Hajime Sakai; Kazuya Sato; Takashi Fukuhara
Journal:  Br J Haematol       Date:  2014-03-10       Impact factor: 6.998

6.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

Review 7.  Adult haemophagocytic syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Armando López-Guillermo; Munther A Khamashta; Xavier Bosch
Journal:  Lancet       Date:  2013-11-27       Impact factor: 79.321

8.  Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.

Authors:  Wyndham H Wilson; Kieron Dunleavy; Stefania Pittaluga; Upendra Hegde; Nicole Grant; Seth M Steinberg; Mark Raffeld; Martin Gutierrez; Bruce A Chabner; Louis Staudt; Elaine S Jaffe; John E Janik
Journal:  J Clin Oncol       Date:  2008-03-31       Impact factor: 44.544

9.  Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.

Authors:  Sébastien Rivière; Lionel Galicier; Paul Coppo; Christophe Marzac; Cedric Aumont; Olivier Lambotte; Laurence Fardet
Journal:  Am J Med       Date:  2014-05-14       Impact factor: 4.965

10.  Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.

Authors:  Eiichi Ishii; Shouichi Ohga; Shinsaku Imashuku; Masaki Yasukawa; Hiroyuki Tsuda; Ikuo Miura; Ken Yamamoto; Hisanori Horiuchi; Kenzo Takada; Koichi Ohshima; Shigeo Nakamura; Naoko Kinukawa; Kazuo Oshimi; Keisei Kawa
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490
View more
  3 in total

1.  Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study.

Authors:  Yubo Pi; Jingshi Wang; Hui Zhou; Xiujin Ye; Xiuhua Sun; Ligen Liu; Xueyi Pan; Zhao Wang
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-19       Impact factor: 4.322

2.  Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.

Authors:  Ailin Zhao; Jinrong Yang; Meng Li; Linfeng Li; Xinai Gan; Jie Wang; He Li; Kai Shen; Yunfan Yang; Ting Niu
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

3.  [Research progress of lymphoma associated hemophagocytic syndrome].

Authors:  X Q Zheng; H Y Zhu; J Y Wang; Lei Fan; Wei Xu; Jianyong Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-09-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.